首页> 外文期刊>Biologicals: Journal of the International Association of Biological Standardization >Detection of mutants in polio vaccine viruses using pooled antipoliovirus monoclonal antibodies.
【24h】

Detection of mutants in polio vaccine viruses using pooled antipoliovirus monoclonal antibodies.

机译:使用合并的抗脊髓灰质炎病毒单克隆抗体检测脊髓灰质炎疫苗病毒中的突变体。

获取原文
获取原文并翻译 | 示例
           

摘要

We prepared six monoclonal antibodies (mAbs) for type 1 polioviruses, and analysed their neutralizing specificities for use in safety tests in oral poliomyelitis vaccine (OPV) production. Pools of two or more individual mAbs showed high neutralizing activity against high-titre (approximately 10(7) CCID (50)/25 microl) of Sabin type 1 virus. It was demonstrated that the pooled mAbs can be utilized effectively in detection tests of adventitious viruses, which are among the safety tests in OPV production. Moreover, some pooled mAbs were shown to be capable of detecting very small amounts of type 1 virulent viruses and mutants in high-titre Sabin type 1 virus suspensions. Neutralizing antibody titres of these pooled mAbs decreased with increasing numbers of mutants containing neurovirulent activity in high-titre Sabin type 1 viruses which were repeatedly passaged in culture. It is expected that these pooled mAbs will contribute greatly to safety tests for OPV production. Copyright 1999 The International Association for Biologicals.
机译:我们制备了用于1型脊髓灰质炎病毒的六种单克隆抗体(mAb),并分析了它们的中和特异性,以用于口服脊髓灰质炎疫苗(OPV)生产的安全性测试。两个或多个单独的mAb池显示出对Sabin 1型病毒的高滴度(约10(7)CCID(50)/ 25微升)具有高中和活性。已证明,合并的mAb可有效用于外来病毒的检测测试,这是OPV生产中的安全性测试之一。此外,已显示某些合并的mAb能够检测高滴度Sabin 1型病毒悬浮液中的极少量1型强毒病毒和突变体。随着在培养物中反复传代的高滴度Sabin 1型病毒中含有神经毒活性的突变体数量的增加,这些合并的mAb的中和抗体滴度会降低。预计这些合并的mAb将极大地促进OPV生产的安全性测试。版权所有1999国际生物制品协会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号